These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 32522589
1. Diospyros kaki leaves inhibit HGF/Met signaling-mediated EMT and stemness features in hepatocellular carcinoma. Ko H, Huh G, Jung SH, Kwon H, Jeon Y, Park YN, Kim YJ. Food Chem Toxicol; 2020 Aug; 142():111475. PubMed ID: 32522589 [Abstract] [Full Text] [Related]
2. Anti-cancer potential of persimmon (Diospyros kaki) leaves via the PDGFR-Rac-JNK pathway. Kim HS, Suh JS, Jang YK, Ahn SH, Raja G, Kim JC, Jung Y, Jung SH, Kim TJ. Sci Rep; 2020 Oct 22; 10(1):18119. PubMed ID: 33093618 [Abstract] [Full Text] [Related]
3. Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma. Nagai T, Arao T, Furuta K, Sakai K, Kudo K, Kaneda H, Tamura D, Aomatsu K, Kimura H, Fujita Y, Matsumoto K, Saijo N, Kudo M, Nishio K. Mol Cancer Ther; 2011 Jan 22; 10(1):169-77. PubMed ID: 21220499 [Abstract] [Full Text] [Related]
4. Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression. Fu R, Jiang S, Li J, Chen H, Zhang X. Med Oncol; 2020 Mar 12; 37(4):24. PubMed ID: 32166604 [Abstract] [Full Text] [Related]
5. C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway. Zhao M, Wang Y, Liu Y, Zhang W, Liu Y, Yang X, Cao Y, Wang S. Cancer Biol Ther; 2019 Mar 12; 20(12):1430-1442. PubMed ID: 31441380 [Abstract] [Full Text] [Related]
6. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1. Gui Y, Khan MGM, Bobbala D, Dubois C, Ramanathan S, Saucier C, Ilangumaran S. World J Gastroenterol; 2017 Sep 28; 23(36):6639-6649. PubMed ID: 29085209 [Abstract] [Full Text] [Related]
7. Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis. Rhee H, Kim HY, Choi JH, Woo HG, Yoo JE, Nahm JH, Choi JS, Park YN. Cancer Res; 2018 Apr 01; 78(7):1619-1631. PubMed ID: 29363547 [Abstract] [Full Text] [Related]
8. Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma. Yu G, Jing Y, Kou X, Ye F, Gao L, Fan Q, Yang Y, Zhao Q, Li R, Wu M, Wei L. PLoS One; 2013 Apr 01; 8(9):e73312. PubMed ID: 24023859 [Abstract] [Full Text] [Related]
9. Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53. Liu WT, Jing YY, Yu GF, Chen H, Han ZP, Yu DD, Fan QM, Ye F, Li R, Gao L, Zhao QD, Wu MC, Wei LX. Cell Cycle; 2016 Apr 01; 15(7):886-94. PubMed ID: 27077227 [Abstract] [Full Text] [Related]
10. LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway. Bu WJ, Fang Z, Li WL, Wang X, Dong MJ, Tao QY, Zhang L, Xu YQ. Eur Rev Med Pharmacol Sci; 2020 Oct 01; 24(20):10452-10461. PubMed ID: 33155201 [Abstract] [Full Text] [Related]
11. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Bozkaya G, Korhan P, Cokaklı M, Erdal E, Sağol O, Karademir S, Korch C, Atabey N. Mol Cancer; 2012 Sep 11; 11():64. PubMed ID: 22962849 [Abstract] [Full Text] [Related]
12. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression. Ha TY, Hwang S, Moon KM, Won YJ, Song GW, Kim N, Tak E, Ryoo BY, Hong HN. Anticancer Res; 2015 Apr 11; 35(4):1967-76. PubMed ID: 25862849 [Abstract] [Full Text] [Related]
13. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling. Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H. Theranostics; 2019 Apr 11; 9(15):4391-4408. PubMed ID: 31285768 [Abstract] [Full Text] [Related]
14. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Huang X, Gan G, Wang X, Xu T, Xie W. Autophagy; 2019 Jul 11; 15(7):1258-1279. PubMed ID: 30786811 [Abstract] [Full Text] [Related]
15. Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells. Firtina Karagonlar Z, Koc D, Iscan E, Erdal E, Atabey N. Cancer Sci; 2016 Apr 11; 107(4):407-16. PubMed ID: 26790028 [Abstract] [Full Text] [Related]
16. CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling. Yu J, Xia X, Dong Y, Gong Z, Li G, Chen GG, Lai PBS. Theranostics; 2021 Apr 11; 11(5):2123-2136. PubMed ID: 33500715 [Abstract] [Full Text] [Related]
17. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications. García-Vilas JA, Medina MÁ. World J Gastroenterol; 2018 Sep 07; 24(33):3695-3708. PubMed ID: 30197476 [Abstract] [Full Text] [Related]
18. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET. He Q, Lin Z, Wang Z, Huang W, Tian D, Liu M, Xia L. Oncogene; 2020 Dec 07; 39(50):7279-7295. PubMed ID: 33046796 [Abstract] [Full Text] [Related]
19. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Zhang R, Gao X, Zuo J, Hu B, Yang J, Zhao J, Chen J. Cancer Sci; 2020 Feb 07; 111(2):406-417. PubMed ID: 31785057 [Abstract] [Full Text] [Related]
20. Anti-neoplastic Effect of Ginkgolide C through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma Cells. Yang MH, Baek SH, Um JY, Ahn KS. Int J Mol Sci; 2020 Nov 05; 21(21):. PubMed ID: 33167504 [Abstract] [Full Text] [Related] Page: [Next] [New Search]